Honz Pharmaceutical Statistics

Total Valuation

SHE:300086 has a market cap or net worth of CNY 2.53 billion. The enterprise value is 2.99 billion.

Market Cap	2.53B
Enterprise Value	2.99B

Important Dates

The next estimated earnings date is Thursday, August 28, 2025.

Earnings Date	Aug 28, 2025
Ex-Dividend Date	n/a

Share Statistics

SHE:300086 has 455.12 million shares outstanding. The number of shares has increased by 1.56% in one year.

Current Share Class	455.12M
Shares Outstanding	455.12M
Shares Change (YoY)	+1.56%
Shares Change (QoQ)	-1.19%
Owned by Insiders (%)	4.16%
Owned by Institutions (%)	1.30%
Float	312.17M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	5.26
PB Ratio	2.19
P/TBV Ratio	2.61
P/FCF Ratio	n/a
P/OCF Ratio	17.61
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-16.64
EV / Sales	6.21
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-4,321.72

Financial Position

The company has a current ratio of 0.86, with a Debt / Equity ratio of 0.46.

Current Ratio	0.86
Quick Ratio	0.44
Debt / Equity	0.46
Debt / EBITDA	n/a
Debt / FCF	-764.34
Interest Coverage	-5.58

Financial Efficiency

Return on equity (ROE) is -15.04% and return on invested capital (ROIC) is -4.22%.

Return on Equity (ROE)	-15.04%
Return on Assets (ROA)	-3.62%
Return on Invested Capital (ROIC)	-4.22%
Return on Capital Employed (ROCE)	-8.01%
Revenue Per Employee	729,122
Profits Per Employee	-272,223
Employee Count	659
Asset Turnover	0.23
Inventory Turnover	1.11

Taxes

Income Tax	-6.71M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +46.83% in the last 52 weeks. The beta is 0.84, so SHE:300086's price volatility has been lower than the market average.

Beta (5Y)	0.84
52-Week Price Change	+46.83%
50-Day Moving Average	5.11
200-Day Moving Average	4.99
Relative Strength Index (RSI)	65.69
Average Volume (20 Days)	19,502,913

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, SHE:300086 had revenue of CNY 480.49 million and -179.40 million in losses. Loss per share was -0.39.

Revenue	480.49M
Gross Profit	250.03M
Operating Income	-119.95M
Pretax Income	-194.06M
Net Income	-179.40M
EBITDA	-61.09M
EBIT	-119.95M
Loss Per Share	-0.39

Full Income Statement

Balance Sheet

The company has 92.97 million in cash and 528.09 million in debt, giving a net cash position of -435.12 million or -0.96 per share.

Cash & Cash Equivalents	92.97M
Total Debt	528.09M
Net Cash	-435.12M
Net Cash Per Share	-0.96
Equity (Book Value)	1.16B
Book Value Per Share	2.48
Working Capital	-74.30M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 143.46 million and capital expenditures -144.15 million, giving a free cash flow of -690,903.

Operating Cash Flow	143.46M
Capital Expenditures	-144.15M
Free Cash Flow	-690,903
FCF Per Share	-0.00

Full Cash Flow Statement

Margins

Gross margin is 52.04%, with operating and profit margins of -24.96% and -37.34%.

Gross Margin	52.04%
Operating Margin	-24.96%
Pretax Margin	-40.39%
Profit Margin	-37.34%
EBITDA Margin	-12.71%
EBIT Margin	-24.96%
FCF Margin	n/a

Dividends & Yields

SHE:300086 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.56%
Shareholder Yield	n/a
Earnings Yield	-7.10%
FCF Yield	-0.03%

Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on September 30, 2015. It was a forward split with a ratio of 1.5.

Last Split Date	Sep 30, 2015
Split Type	Forward
Split Ratio	1.5

Scores

SHE:300086 has an Altman Z-Score of 1.29 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.29
Piotroski F-Score	3